« Back
Home /
Faldaprevir

Faldaprevir

Item no.	TMO-T19685-500mg
Manufacturer	TargetMol
CASRN	801283-95-4
Amount	500 mg
Quantity options	100 mg 10 mg 1 mg 25 mg 500 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Formula	C40H49BrN6O9S
Smiles	N(C(=O)[C@H]1N(C([C@@H](NC(OC2CCCC2)=O)C(C)(C)C)=O)C[C@H](OC=3C4=C(N=C(C3)C=5N=C(NC(C(C)C)=O)SC5)C(Br)=C(OC)C=C4)C1)[C@@]6(C(O)=O)[C@H](C=C)C6
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BI201335,BI-201335
Shipping Condition	Cool pack
Available
Manufacturer - Targets	HCV Protease
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	869.82
Description	Faldaprevir is an orally effective, selective, non-covalent HCV NS3/4A protease inhibitor with high inhibitory activity against HCV 1a and 1b genotypes (Ki=2.6 nM &2.0 nM).Faldaprevir inhibits viral replication by blocking the breakdown of viral precursor proteins, and is well tolerated with good antiviral activity against hepatitis C virus.
Pathways	Microbiology/Virology\|\|\|Proteases/Proteasome
Bioactivity	Faldaprevir is an effective NS3/NS4A protease inhibitor potentially for the treatment of HCV infection. Faldaprevir is known to inhibit P-glycoprotein, CYP3A4, and UDP-glucuronosyltransferase 1A1.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 500 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question